Reconstitution of thymic function in HIV-1 patients treated with highly active antiretroviral therapy

Clinical Immunology

Volumn 106, Issue 2, 2003, Pages 95-105

  Ye, Ping ^a   Kourtis, Athena P ^b   Kirschner, Denise E ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

HAART; Immune reconstitution; Mathematical model; Pediatric infection; Thymus

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE PLUS ZIDOVUDINE; LAMIVUDINE PLUS RITONAVIR PLUS ZIDOVUDINE; NUCLEOSIDE DERIVATIVE; RNA DIRECTED DNA POLYMERASE INHIBITOR; UNCLASSIFIED DRUG; ZIDOVUDINE;

ARTICLE; BLOOD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SIMULATION; DRUG EFFICACY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MATHEMATICAL MODEL; PREDICTION; PRIORITY JOURNAL; THYMUS FUNCTION; VIRUS LOAD; VIRUS REPLICATION; VIRUS STRAIN;

EID: 0345268655     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1521-6616(02)00024-4     Document Type: Article

References (33)

1. Sempowski G.D., Haynes B.F. Immune reconstitution in patients with HIV infection. Annu. Rev. Med. 53:2002;269-284.
2. Douek D.C., Koup R.A., McFarland R.D., Sullivan J.L., Luzuriaga K. Effect of HIV on thymic function before and after antiretroviral therapy in children. J. Infect. Dis. 181:2000;1479-1482.
3. Gibb D.M., Newberry A., Klein N., de Rossi A., Grosch-Woerner I., Babiker A. Immune repopulation after HAART in previously untreated HIV-1-infected children. Paediatric European Network for Treatment of AIDS (PENTA) Steering Committee [letter]. Lancet. 355:2000;1331-1332.
4. + T lymphocyte regeneration after anti-retroviral therapy in HIV-1-infected children and adult patients. Clin. Exp. Immunol. 119:2000;493-498.
5. Franco J.M., Rubio A., Martinez-Moya M., Leal M., Merchante E., Sanchez-Quijano A., Lissen E. T-cell repopulation and thymic volume in HIV-1-infected adult patients after highly active antiretroviral therapy. Blood. 99:2002;3702-3706.
6. Douek D.C., McFarland R.D., Keiser P.H., Gage E.A., Massey J.M., Haynes B.F., Polis M.A., Haase A.T., Feinberg M.B., Sullivan J.L., Jamieson B.D., Zack J.A., Picker L.J., Koup R.A. Changes in thymic function with age and during the treatment of HIV infection [see comments]. Nature. 396:1998;690-695.
7. Zhang L., Lewin S.R., Markowitz M., Lin H.H., Skulsky E., Karanicolas R., He Y., Jin X., Tuttleton S., Vesanen M., Spiegel H., Kost R., van Lunzen J., Stellbrink H.J., Wolinsky S., Borkowsky W., Palumbo P., Kostrikis L.G., Ho D.D. Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy. J. Exp. Med. 190:1999;725-732.
8. Smith K.Y., Valdez H., Landay A., Spritzler J., Kessler H.A., Connick E., Kuritzkes D., Gross B., Francis I., McCune J.M., Lederman M.M. Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy. J. Infect. Dis. 181:2000;141-147.
9. Vigano A., Vella S., Saresella M., Vanzulli A., Bricalli D., Di Fabio S., Ferrante P., Andreotti M., Pirillo M., Dally L.G., Clerici M., Principi N. Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volume. AIDS. 14:2000;251-261.
10. Markert M.L., Alvarez-McLeod A.P., Sempowski G.D., Hale L.P., Horvatinovich J.M., Weinhold K.J., Bartlett J.A., D'Amico T.A., Haynes B.F. Thymopoiesis in HIV-infected adults after highly active antiretroviral therapy. AIDS Res. Hum. Retroviruses. 17:2001;1635-1643.
11. Kolte L., Dreves A.M., Ersboll A.K., Strandberg C., Jeppesen D.L., Nielsen J.O., Ryder L.P., Nielsen S.D. Association between larger thymic size and higher thymic output in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy. J. Infect. Dis. 185:2002;1578-1585.
12. Schrager L.K., D'Souza M.P. Cellular and anatomical reservoirs of HIV-1 in patients receiving potent antiretroviral combination therapy. J. Am. Med. Assoc. 280:1998;67-71.
13. Zhang H., Dornadula G., Beumont M., Livornese L. Jr., Van Uitert B., Henning K., Pomerantz R.J. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. N. Engl. J. Med. 339:1998;1803-1809.
14. Kitami A., Suzuki T., Kamio Y., Suzuki S. Chemotherapy of thymic carcinoma: Analysis of seven cases and review of the literature. Jpn. J. Clin. Oncol. 31:2001;601-604.
15. Foudraine N.A., Hoetelmans R.M., Lange J.M., de Wolf F., van Benthem B.H., Maas J.J., Keet I.P., Portegies P. Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine. Lancet. 351:1998;1547-1551.
16. Haworth S.J., Christofalo B., Anderson R.D., Dunkle L.M. A single-dose study to assess the penetration of stavudine into human cerebrospinal fluid in adults. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 17:1998;235-238.
17. Lewis L.L., Venzon D., Church J., Farley M., Wheeler S., Keller A., Rubin M., Yuen G., Mueller B., Sloas M., Wood L., Balis F., Shearer G.M., Brouwers P., Goldsmith J., Pizzo P.A. Lamivudine in children with human immunodeficiency virus infection A phase I/II study. The National Cancer Institute Pediatric Branch-Human Immunodeficiency Virus Working Group . J. Infect. Dis. 174:1996;16-25.
18. van Praag R.M., Weverling G.J., Portegies P., Jurriaans S., Zhou X.J., Turner-Foisy M.L., Sommadossi J.P., Burger D.M., Lange J.M., Hoetelmans R.M., Prins J.M. Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavir. AIDS. 14:2000;1187-1194.
19. Kravcik S., Gallicano K., Roth V., Cassol S., Hawley-Foss N., Badley A., Cameron D.W. Cerebrospinal fluid HIV RNA and drug levels with combination ritonavir and saquinavir. J. Acquir. Immune. Defic. Syndr. 21:1999;371-375.
20. Ye P., Kirschner D.E. Reevaluation of T cell receptor excision circles as a measure of human recent thymic emigrants. J. Immunol. 168:2002;4968-4979.
21. Ye P., Kourtis A.P., Kirschner D.E. The effects of different HIV-1 strains on human thymic function. AIDS Res. Hum. Retroviruses. 18:2002;1239-1251.
22. Kourtis A.P., Ibegbu C., Nahmias A.J., Lee F.K., Clark W.S., Sawyer M.K., Nesheim S. Early progression of disease in HIV-infected infants with thymus dysfunction [published erratum appears in N. Engl. J. Med. 336(8) (1997) 595]. N. Engl. J. Med. 335:1996;1431-1436.
23. van Rossum A.M., Geelen S.P., Hartwig N.G., Wolfs T.F., Weemaes C.M., Scherpbier H.J., van Lochem E.G., Hop W.C., Schutten M., Osterhaus A.D., Burger D.M., de Groot R. Results of 2 years of treatment with protease-inhibitor-containing antiretroviral therapy in Dutch children infected with human immunodeficiency virus type 1. Clin. Infect. Dis. 34:2002;1008-1016.
24. Berger E.A., Doms R.W., Fenyo E.M., Korber B.T., Littman D.R., Moore J.P., Sattentau Q.J., Schuitemaker H., Sodroski J., Weiss R.A. A new classification for HIV-1 [letter]. Nature. 391:1998;240.
25. Markert M.L., Hicks C.B., Bartlett J.A., Harmon J.L., Hale L.P., Greenberg M.L., Ferrari G., Ottinger J., Boeck A., Kloster A.L., McLaughlin T.M., Bleich K.B., Ungerleider R.M., Lyerly H.K., Wilkinson W.E., Rousseau F.S., Heath-Chiozzi M.E., Leonard J.M., Haase A.T., Shaw G.M., Bucy R.P., Douek D.C., Koup R.A., Haynes B.F., Bolognesi D.P., Weinhold K.J. Effect of highly active antiretroviral therapy and thymic transplantation on immunoreconstitution in HIV infection. AIDS Res. Hum. Retroviruses. 16:2000;403-413.
26. Bohler T., Walcher J., Holzl-Wenig G., Geiss M., Buchholz B., Linde R., Debatin K.M. Early effects of antiretroviral combination therapy on activation, apoptosis and regeneration of T cells in HIV-1-infected children and adolescents. AIDS. 13:1999;779-789.
27. Isgro A., Mezzaroma I., Aiuti A., De Vita L., Franchi F., Pandolfi F., Alario C., Ficara F., Riva E., Antonelli G., Aiuti F. Recovery of hematopoietic activity in bone marrow from human immunodeficiency virus type-1-infected patients during highly active antiretroviral therapy [In Process Citation]. AIDS Res. Hum. Retroviruses. 16:2000;1471-1479.
28. Kitchen S.G., Killian S., Giorgi J.V., Zack J.A. Functional reconstitution of thymopoiesis after human immunodeficiency virus infection. J. Virol. 74:2000;2943-2948.
29. Withers-Ward E.S., Amado R.G., Koka P.S., Jamieson B.D., Kaplan A.H., Chen I.S., Zack J.A. Transient renewal of thymopoiesis in HIV-infected human thymic implants following antiviral therapy. Nat. Med. 3:1997;1102-1109.
30. Kourtis A.P., Bulterys M., Nesheim S.R., Lee F.K. Understanding the timing of HIV transmission from mother to infant. Am. Med. Assoc. 285:2001;709-712.
31. Hayes K.A., Phipps A.J., Francke S., Mathes L.E. Antiviral therapy reduces viral burden but does not prevent thymic involution in young cats infected with feline immunodeficiency virus. Antimicrob. Agents. Chemother. 44:2000;2399-2405.
32. Groothuis D.R., Levy R.M. The entry of antiviral and antiretroviral drugs into the central nervous system. J. Neurovirol. 3:1997;387-400.
33. Gorochov G., Neumann A.U., Kereveur A., Parizot C., Li T., Katlama C., Karmochkine M., Raguin G., Autran B., Debre P. Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy [see comments]. Nat. Med. 4:1998;215-221.